Marga Ortigas-Wedekind
Director/Board Member at HEARTBEAM, INC.
Net worth: 188 602 $ as of 2024-04-29
Profile
Marga Ortigas-Wedekind is currently an Independent Director at HeartBeam, Inc., and a Director at Total Flow Cannula Ltd.
She is also the Chief Commercial Officer at Fogarty Innovation LLC since 2019.
In her former positions, Ms. Ortigas-Wedekind worked as a Marketing Director at Guidant Corp.
and as a Director at Itamar Medical Ltd.
She also served as the Director-Market Development at Guidant Vascular Intervention from 1990 to 2000.
From 2009 to 2015, she was the EVP-Global Marketing & Product Development at Omnicell, Inc. Ms. Ortigas-Wedekind held the position of SVP-Marketing, Development & Clinical Affairs at Xoft, Inc. in 2002.
From 2015 to 2019, she was the Executive Vice President-Marketing at iRhythm Technologies, Inc. She also worked as the Vice President-Sales & Marketing at Pro-Duct Health, Inc.Ms. Ortigas-Wedekind completed her undergraduate studies at Wellesley College.
She also holds an MBA from Stanford Graduate School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HEARTBEAM, INC.
0.36% | 2024-03-30 | 95,932 ( 0.36% ) | 188 602 $ | 2024-04-29 |
Marga Ortigas-Wedekind active positions
| Companies | Position | Start |
|---|---|---|
| HEARTBEAM, INC. | Director/Board Member | - |
| Fogarty Innovation LLC | Corporate Officer/Principal | 2019-11-30 |
Total Flow Cannula Ltd.
 Total Flow Cannula Ltd. Medical SpecialtiesHealth Technology Total Flow Cannula Ltd. develops novel medical devices. The Canadian company was founded in 2019 by Hillary Pierce and Luke Harris, with Hillary Pierce serving as CEO since 2019. | Director/Board Member | - |
Former positions of Marga Ortigas-Wedekind
| Companies | Position | End |
|---|---|---|
| IRHYTHM TECHNOLOGIES, INC. | Sales & Marketing | 2019-06-30 |
| OMNICELL, INC. | Sales & Marketing | 2015-03-31 |
Xoft, Inc.
 Xoft, Inc. Data Processing ServicesTechnology Services Xoft, Inc. develops Electronic Brachytherapy systems for radiation therapy applications. Its products include the Axxent Controller, which utilizes a miniaturized high dose rate (HDR) X-ray source to apply radiation directly to the cancerous tumor bed; Axxent HDR X-ray Source, a low energy radiation treatment without the use of radioactive isotopes; Axxent Applicators, which provides a channel for the Axxent X-ray Source to deliver high dose rate, low energy radiation directly to the targeted area; and Axxent Accessories, an accessory product line designed to support and aid a physician during a procedure or treatment of cancer radiation. The company was founded by Michael Forman in 1998 and is headquartered in San Jose, CA. | Chief Tech/Sci/R&D Officer | 2008-11-30 |
| Guidant Vascular Intervention | Corporate Officer/Principal | 2000-11-30 |
| ITAMAR MEDICAL LTD. | Director/Board Member | - |
Training of Marga Ortigas-Wedekind
| Wellesley College | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| OMNICELL, INC. | Technology Services |
| IRHYTHM TECHNOLOGIES, INC. | Health Technology |
| HEARTBEAM, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Health Technology |
Xoft, Inc.
Xoft, Inc. Data Processing ServicesTechnology Services Xoft, Inc. develops Electronic Brachytherapy systems for radiation therapy applications. Its products include the Axxent Controller, which utilizes a miniaturized high dose rate (HDR) X-ray source to apply radiation directly to the cancerous tumor bed; Axxent HDR X-ray Source, a low energy radiation treatment without the use of radioactive isotopes; Axxent Applicators, which provides a channel for the Axxent X-ray Source to deliver high dose rate, low energy radiation directly to the targeted area; and Axxent Accessories, an accessory product line designed to support and aid a physician during a procedure or treatment of cancer radiation. The company was founded by Michael Forman in 1998 and is headquartered in San Jose, CA. | Technology Services |
Pro-Duct Health, Inc.
 Pro-Duct Health, Inc. Medical SpecialtiesHealth Technology Pro·Duct Health manufactures the devices used in ductal lavage. The company is dedicated to eradicating breast cancer by enabling the earliest possible detection of breast pre-cancer and cancer | Health Technology |
Itamar Medical Ltd.
 Itamar Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets the WatchPAT and EndoPAT products. The WatchPAT diagnoses sleep apnea, a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur in 1995 and is headquartered in Caesarea, Israel. | Electronic Technology |
| Guidant Vascular Intervention | |
| Fogarty Innovation LLC | |
Total Flow Cannula Ltd.
Total Flow Cannula Ltd. Medical SpecialtiesHealth Technology Total Flow Cannula Ltd. develops novel medical devices. The Canadian company was founded in 2019 by Hillary Pierce and Luke Harris, with Hillary Pierce serving as CEO since 2019. | Health Technology |
- Stock Market
- Insiders
- Marga Ortigas-Wedekind
